[
  {
    "ts": "2026-02-16T14:57:00+00:00",
    "headline": "My 1 Top AI Healthcare Stock to Buy and Hold Forever",
    "summary": "The stock has averaged annual gains of nearly 25% over the past decade.",
    "url": "https://www.fool.com/investing/2026/02/16/my-1-top-ai-healthcare-stock-to-buy-and-hold-isrg/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "4f420a5c-a881-3a76-a8f6-0bf20c076b3c",
      "content": {
        "id": "4f420a5c-a881-3a76-a8f6-0bf20c076b3c",
        "contentType": "STORY",
        "title": "My 1 Top AI Healthcare Stock to Buy and Hold Forever",
        "description": "",
        "summary": "The stock has averaged annual gains of nearly 25% over the past decade.",
        "pubDate": "2026-02-16T14:57:00Z",
        "displayTime": "2026-02-16T14:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/5d51ce65af3a1e186eba0b7fb664f476",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A surgeon is performing an operation with several robotic arms helping. ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ikwlA7zhnUe4AFvbs.jaew--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/5d51ce65af3a1e186eba0b7fb664f476.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/armlFSs42JLwWjuoXr2s7w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/5d51ce65af3a1e186eba0b7fb664f476.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/16/my-1-top-ai-healthcare-stock-to-buy-and-hold-isrg/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-top-ai-healthcare-stock-145700605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-16T15:52:00+00:00",
    "headline": "TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial",
    "summary": "TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use.",
    "url": "https://finance.yahoo.com/news/tmdx-wins-full-fda-ide-155200995.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c4468f67-119b-3826-873e-3263fa39efa1",
      "content": {
        "id": "c4468f67-119b-3826-873e-3263fa39efa1",
        "contentType": "STORY",
        "title": "TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial",
        "description": "",
        "summary": "TransMedics secures full FDA IDE approval for its OCS ENHANCE Heart trial, clearing a key hurdle and advancing its push to expand heart transplant use.",
        "pubDate": "2026-02-16T15:52:00Z",
        "displayTime": "2026-02-16T15:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5efl.hfUE9GqHAAzVZOyrQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZSi1jC0ojY5JbN8IL4CqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tmdx-wins-full-fda-ide-155200995.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tmdx-wins-full-fda-ide-155200995.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]